HomeCompareHIMY vs PM

HIMY vs PM: Dividend Comparison 2026

HIMY yields 102.38% · PM yields 3.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HIMY wins by $4.24M in total portfolio value
10 years
HIMY
HIMY
● Live price
102.38%
Share price
$5.43
Annual div
$5.56
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.29M
Annual income
$1,469,249.94
Full HIMY calculator →
PM
Philip Morris International
● Live price
3.49%
Share price
$164.83
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,502.61
Full PM calculator →

Portfolio growth — HIMY vs PM

📍 HIMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHIMYPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HIMY + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HIMY pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HIMY
Annual income on $10K today (after 15% tax)
$8,702.51/yr
After 10yr DRIP, annual income (after tax)
$1,248,862.45/yr
PM
Annual income on $10K today (after 15% tax)
$297.03/yr
After 10yr DRIP, annual income (after tax)
$2,127.22/yr
At 15% tax rate, HIMY beats the other by $1,246,735.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HIMY + PM for your $10,000?

HIMY: 50%PM: 50%
100% PM50/50100% HIMY
Portfolio after 10yr
$2.17M
Annual income
$735,876.28/yr
Blended yield
33.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

HIMY
No analyst data
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.9% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HIMY buys
0
PM buys
5
PoliticianChamberTickerTypeAmountDate
Julia Letlow🏢 House$PM▼ Sell$1,001 - $15,0002026-02-05
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$PM▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$PM▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$PM▲ Buy$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$PM▲ Buy$15,001 - $50,0002025-09-05
Ro Khanna🏢 House$PM▲ Buy$15,001 - $50,0002025-08-26
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-08-14
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-07-22
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHIMYPM
Forward yield102.38%3.49%
Annual dividend / share$5.56$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$4.29M$49.6K
Annual income after 10y$1,469,249.94$2,502.61
Total dividends collected$3.84M$11.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: HIMY vs PM ($10,000, DRIP)

YearHIMY PortfolioHIMY Income/yrPM PortfolioPM Income/yrGap
1← crossover$20,938$10,238.24$11,650$409.56+$9.3KHIMY
2$42,439$20,034.66$13,592$497.49+$28.8KHIMY
3$83,360$37,950.61$15,882$605.21+$67.5KHIMY
4$158,863$69,667.68$18,589$737.41+$140.3KHIMY
5$294,066$124,083.06$21,794$899.94+$272.3KHIMY
6$529,311$214,660.30$25,597$1,100.16+$503.7KHIMY
7$927,468$361,105.31$30,118$1,347.30+$897.4KHIMY
8$1,583,732$591,341.15$35,505$1,652.97+$1.55MHIMY
9$2,638,300$943,706.64$41,940$2,031.88+$2.60MHIMY
10$4,292,231$1,469,249.94$49,643$2,502.61+$4.24MHIMY

HIMY vs PM: Complete Analysis 2026

HIMYStock

The Defiance Daily Target 2X Long HIMS ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Hims & Hers Health, Inc. (NYSE: HIMS). Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds and there is no guarantee that the Fund will meet its stated objective. The Fund should not be expected to provide 2 times the cumulative return of HIMS for periods greater than a single trading day.

Full HIMY Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this HIMY vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HIMY vs SCHDHIMY vs JEPIHIMY vs OHIMY vs KOHIMY vs MAINHIMY vs MOHIMY vs BTIHIMY vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.